BioCentury | Mar 6, 2021
Finance

With $106M series C, Tenaya will bring AAV manufacturing in-house

...in adults and children due to mutations in the MYBPC3 gene. The company, which spun out of the Gladstone Institutes in...
...align.”TARGETSMYBPC3 – Myosin binding protein C cardiac MYOCD – Myocardin Danielle Golovin RTW Investments LLC Tenaya Therapeutics Inc. RTW Investments Gladstone Institutes Fidelity...
BioCentury | Jan 30, 2021
Translation in Brief

Gladstone-UCSF research center to focus on brain diseases; plus a mammography-based prediction algorithm, PharmaMar and an intracellular glycoprotein that blocks phagocytosis

...By Danielle Golovin, Staff Writer Gladstone, UCSF pair up to tackle brain diseasesScientists at the Gladstone Institutes...
...Medicine at Mount Sinai University of California San Francisco PharmaMar S.A. Gilead Sciences Inc. Massachusetts Institute of Technology University of Michigan Gladstone Institutes Eukaryotic...
BioCentury | Dec 31, 2020
Distillery Therapeutics

SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations

...status unavailablePUBLICATION DETAILS: Gut, P. et al. Nat. Commun.; published online Nov. 23, 2020doi:10.1038/s41467-020-19743-4CONTACT: Philipp Gut, Gladstone Institutes...
...Calif.; Nestlé Institute of Health Sciences, Lausanne, Switzerlandemail: philipp.gut@rd.nestle.comCONTACT: Birgit Schilling, Buck Institute for Research on Aging, Novato, Calif.email: bschilling@buckinstitute.orgCONTACT: Eric Verdin, Gladstone Institutes...
...Francisco, Calif.; Buck Institute for Research on Aging, Novato, Calif.email: everdin@buckinstitute.orgCONTACT: Anu Suomalainen, University of Helsinki, Helsinki, Finlandemail: anu.wartiovaara@helsinki.fi Claire Quang Gladstone Institutes University...
BioCentury | Aug 22, 2020
Translation in Brief

IPD’s synthetic bio unlocks target combos for cell therapy; plus Merck’s oral STING agonist, Surrozen’s regenerative therapy and more

...cells that depend on ecDNA (see “Boundless Bio”).Gladstone team analyzes T cells of recovered COVID-19 patientsA Gladstone Institutes...
...MMTV integration site family member 3A ZNRF3 – Zinc and ring finger 3 Danielle Golovin Merck & Co. Inc. Gladstone Institutes Surrozen...
BioCentury | May 8, 2020
Targets & Mechanisms

New Gladstone institutes point to emerging concepts in virology, immunology

...a viral outbreak. Founded with a focus on cardiovascular disease in 1979, the San Francisco-based Gladstone Institutes...
BioCentury | Apr 3, 2020
Distillery Therapeutics

Tau identified as target for autism associated with epilepsy syndromes

...published online March 2, 2020 doi:10.1016/j.neuron.2020.01.038 CONTACT: Lennart Mucke, Gladstone Institutes, San Francisco, Calif. email: lennart.mucke@gladstone.ucsf.edu Claire Quang Gladstone Institutes Microtubule-associated...
BioCentury | Jan 17, 2020
Preclinical News

Jan 16 Preclinical Quick Takes: Deerfield's Orchard partners with Yeda; Acuitas-Penn flu vaccine in newborns; plus Regeneron, Genentech-Gladstone and Banyan

...NMDA receptor for Dravet, AD In a Cell Reports the paper , Genentech Inc. and Gladstone Institutes...
...bti, protein biomarkers) Yeda Research and Development Co. Ltd. Weizmann Institute of Science University of Pennsylvania Regeneron Pharmaceuticals Inc. Genentech Inc. Gladstone Institutes Banyan...
BioCentury | Dec 27, 2019
Company News

Two-year-old Xyphos gains exit as Astellas scoops up CAR T switch platform

...candidate which it expects to be in the clinic by 2021. In collaboration with the Gladstone Institutes...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the mAb. Engineering organs with machine learning In a paper published in Cell Systems , Gladstone Institutes...
...Tumor necrosis factor receptor superfamily member 11b BioCentury Staff Excision BioTherapeutics Inc. Caribou Biosciences Inc. Kymab Group Ltd. Oligomerix Inc. Gladstone Institutes Boston...
BioCentury | Oct 25, 2019
Tools & Techniques

Gladstone, Xyphos target universal CARs to latent HIV

...Xyphos teamed up with the Gladstone Institutes to direct the company’s universal CAR Ts to cells latently...
...company is moving forward with autologous therapies as allogeneic cells undergo clinical validation. Sandi Wong, Staff Writer Gladstone Institutes Xyphos...
Items per page:
1 - 10 of 128
BioCentury | Mar 6, 2021
Finance

With $106M series C, Tenaya will bring AAV manufacturing in-house

...in adults and children due to mutations in the MYBPC3 gene. The company, which spun out of the Gladstone Institutes in...
...align.”TARGETSMYBPC3 – Myosin binding protein C cardiac MYOCD – Myocardin Danielle Golovin RTW Investments LLC Tenaya Therapeutics Inc. RTW Investments Gladstone Institutes Fidelity...
BioCentury | Jan 30, 2021
Translation in Brief

Gladstone-UCSF research center to focus on brain diseases; plus a mammography-based prediction algorithm, PharmaMar and an intracellular glycoprotein that blocks phagocytosis

...By Danielle Golovin, Staff Writer Gladstone, UCSF pair up to tackle brain diseasesScientists at the Gladstone Institutes...
...Medicine at Mount Sinai University of California San Francisco PharmaMar S.A. Gilead Sciences Inc. Massachusetts Institute of Technology University of Michigan Gladstone Institutes Eukaryotic...
BioCentury | Dec 31, 2020
Distillery Therapeutics

SIRT5 overexpression could rescue mitochondrial disease induced by SUCLA2 mutations

...status unavailablePUBLICATION DETAILS: Gut, P. et al. Nat. Commun.; published online Nov. 23, 2020doi:10.1038/s41467-020-19743-4CONTACT: Philipp Gut, Gladstone Institutes...
...Calif.; Nestlé Institute of Health Sciences, Lausanne, Switzerlandemail: philipp.gut@rd.nestle.comCONTACT: Birgit Schilling, Buck Institute for Research on Aging, Novato, Calif.email: bschilling@buckinstitute.orgCONTACT: Eric Verdin, Gladstone Institutes...
...Francisco, Calif.; Buck Institute for Research on Aging, Novato, Calif.email: everdin@buckinstitute.orgCONTACT: Anu Suomalainen, University of Helsinki, Helsinki, Finlandemail: anu.wartiovaara@helsinki.fi Claire Quang Gladstone Institutes University...
BioCentury | Aug 22, 2020
Translation in Brief

IPD’s synthetic bio unlocks target combos for cell therapy; plus Merck’s oral STING agonist, Surrozen’s regenerative therapy and more

...cells that depend on ecDNA (see “Boundless Bio”).Gladstone team analyzes T cells of recovered COVID-19 patientsA Gladstone Institutes...
...MMTV integration site family member 3A ZNRF3 – Zinc and ring finger 3 Danielle Golovin Merck & Co. Inc. Gladstone Institutes Surrozen...
BioCentury | May 8, 2020
Targets & Mechanisms

New Gladstone institutes point to emerging concepts in virology, immunology

...a viral outbreak. Founded with a focus on cardiovascular disease in 1979, the San Francisco-based Gladstone Institutes...
BioCentury | Apr 3, 2020
Distillery Therapeutics

Tau identified as target for autism associated with epilepsy syndromes

...published online March 2, 2020 doi:10.1016/j.neuron.2020.01.038 CONTACT: Lennart Mucke, Gladstone Institutes, San Francisco, Calif. email: lennart.mucke@gladstone.ucsf.edu Claire Quang Gladstone Institutes Microtubule-associated...
BioCentury | Jan 17, 2020
Preclinical News

Jan 16 Preclinical Quick Takes: Deerfield's Orchard partners with Yeda; Acuitas-Penn flu vaccine in newborns; plus Regeneron, Genentech-Gladstone and Banyan

...NMDA receptor for Dravet, AD In a Cell Reports the paper , Genentech Inc. and Gladstone Institutes...
...bti, protein biomarkers) Yeda Research and Development Co. Ltd. Weizmann Institute of Science University of Pennsylvania Regeneron Pharmaceuticals Inc. Genentech Inc. Gladstone Institutes Banyan...
BioCentury | Dec 27, 2019
Company News

Two-year-old Xyphos gains exit as Astellas scoops up CAR T switch platform

...candidate which it expects to be in the clinic by 2021. In collaboration with the Gladstone Institutes...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the mAb. Engineering organs with machine learning In a paper published in Cell Systems , Gladstone Institutes...
...Tumor necrosis factor receptor superfamily member 11b BioCentury Staff Excision BioTherapeutics Inc. Caribou Biosciences Inc. Kymab Group Ltd. Oligomerix Inc. Gladstone Institutes Boston...
BioCentury | Oct 25, 2019
Tools & Techniques

Gladstone, Xyphos target universal CARs to latent HIV

...Xyphos teamed up with the Gladstone Institutes to direct the company’s universal CAR Ts to cells latently...
...company is moving forward with autologous therapies as allogeneic cells undergo clinical validation. Sandi Wong, Staff Writer Gladstone Institutes Xyphos...
Items per page:
1 - 10 of 128